Skip to main content

Josephine D. Abraham, MD, MPH, FASN


View Full Profile

Kelsey Barrell, MD


View Full Profile

Spencer J. Carter, MD


View Full Profile

Amandeep Godara, MBBS


View Full Profile

Josef Stehlik, MD, MPH


View Full Profile

Jill Stratford Waldron, MSN, GNP, MS


View Full Profile

Raymond Comenzo, MD

Tufts Medical Center, Boston, Massachusetts

View Full Profile

Anita D'Souza, MD, MS

Medical College of Wisconsin, Milwaukee, Wisconsin

Dr. D’Souza is a distinguished physician in the field of hematology/oncology and transplant/cell therapy, currently serving as the Chair of the Plasma cell disorders group at the Froedtert & Medical College of Wisconsin Cancer Center in Milwaukee, WI. She is an expert in the management of plasma cell disorders, with a particular focus on light chain (AL) amyloidosis. Dr D’Souza is also actively engaged in research, leading an NIH-funded program aimed at developing pathways for the early diagnosis of AL amyloidosis and investigating patient-reported outcomes and health-related quality of life. In addition, she is a principal investigator on numerous clinical trials exploring innovative therapies for patients with AL amyloidosis and multiple myeloma.

View Full Profile

Tibor Kovacsovics, MD

City of Hope Phoenix, Phoenix, Arizona

View Full Profile

Isabelle Lousada

Founder and CEO, Amyloidosis Research Consortium, Newton, Massachusetts

View Full Profile

Julie Lynch, PhD, RN, MBA, FAAN

George E. Wahlen VA, Salt Lake City, Utah

Dr. Lynch is Director for Precision Medicine research team for VA Informatics and Computing Infrastructure (VINCI), a national resource center for the Department of Veterans Affairs (VA), and an Adjunct Professor at the University of Utah, School of Medicine, Epidemiology Department. In these roles, Dr. Lynch works as an Investigator leading or supporting national research projects that evaluate equity and quality of precision medicine care for Veterans. Trained as an advanced practice oncology nurse, Dr. Lynch works in conjunction with VA national clinical leadership to ensure her team’s research findings are translated to improvements in the quality of clinical care for Veterans. These efforts have generated nearly 100 publications analyzing precision medicine care among Veterans.

The VINCI Precision Medicine Team has in-depth expertise in the analysis and curation of VA electronic health record data, structured and unstructured data within the VA’s  corporate data warehouse (CDW), and the various data science informatics tools such as natural language processing and machine learning. Dr. Lynch is the innovator of the VA GDx, a project that collects and structures clinical genetic test results on Veterans. She is also an investigator on several Million Veteran Program genetic biorepository research projects.

Dr. Lynch lives and works near Boston, Massachusetts. In addition to her professional role serving Veterans, Dr. Lynch is the mother of two young-adults, cares for aging parents, and enjoys her long-term partnership with a fellow research scientist.

View Full Profile

Ahmad Masri, MD, MS

Oregon Health and Science University, Portland, Oregon

Dr. Ahmad Masri is the Director of the Cardiac Amyloidosis Program and the Hypertrophic Cardiomyopathy Center at the Oregon Health & Science University.

View Full Profile

Mathew Maurer, MD

Columbia University Irving Medical Center, New York Presbyterian Hospital; New York City, NY

Dr. Maurer is a general internist and geriatric cardiologist with advanced training in heart failure and cardiac transplantation.  He is the Arnold and Arlene Goldstein Professor of Cardiology at Columbia University Irving Medical Center, Vagelos College of Physicians & Surgeons, where directs the Clinical Cardiovascular Research Laboratory for the Elderly (CCRLE). Dr. Maurer is a member of the Advanced Cardiac Care Center at NewYork Presbyterian Hospital – Columbia Campus. 

He has published over 350 articles including peer reviewed manuscripts, reviews and book chapters. He was Chair of the American College of Cardiology’s Geriatric Cardiology Member Section, which is the largest organization dedicated to advancing the care of older adults with cardiovascular disease. He was co-chair of the Steering Committee of the ATTR-ACT trial showing tafamidis was a safe and effective therapy for transthyretin amyloid cardiomyopathy.   Throughout his career, he has promulgated an approach to older adults with cardiovascular disease that offers the best of both geriatric and cardiovascular medicine in which a comprehensive holistic approach to enhance functional capacity and quality of life is at the forefront of emerging techniques to address cardiovascular physiologic derangement that disproportionately afflict older adults. 

View Full Profile

Jose N. Nativi Nicolau, MD

Mayo Clinic, Jacksonville, Florida

View Full Profile

Laurence Parker, PhD

University of Utah, Salt Lake City, Utah

View Full Profile

Ashutosh Wechalekar, MBBS, MD, FRCP, FRCPath, DM

University College London, London, United Kingdom

View Full Profile